Eli Lilly and Co
LLY
1,299.50
+59.16
+4.77%
Eli Lilly and Co
US · LLY
#17 by market cap
Listed 1970
1,299.50
+59.16
+4.77%
Live - 5344 symbols - heartbeat 451s ago
· 2026-10-20 10:50
About Eli Lilly and Co
Eli Lilly is a pharmaceutical maker whose portfolio spans diabetes, oncology, immunology and neuroscience treatments. Founded by Eli Lilly in Indianapolis in 1876, the company remains headquartered there and is one of the oldest continuously operating drugmakers in the country.
- Founded
- 1876
- CEO
- Mr. David A. Ricks
- Employees
- 50,000
- Headquarters
- Indianapolis, Indiana, United States of America
- Fiscal year end
- 12-31
- Website
- lilly.com
Company profile
- Exchange
- US
- Symbol
- LLY
- Market-cap rank
- #17
- Listing date
- 1970-01-01
- Market cap
- 1.22T
- Float cap
- 1.22T
- Shares out
- 941.36M
- Float shares
- 938.95M
Sectors & themes
Drug Manufacturers - General
Weight Loss Drugs
Donald Trump
Donald Trump
Global medical industry
Regular Savings Plan
Fractional Shares JP
Quote time 2026-10-20 10:50:13 · For reference only, not investment advice and not tailored to your situation.
the GLP-1 demand curve still doesn’t look like it’s topping, manufacturing capacity is the actual bottleneck here not demand, which is a good problem to have.